$EXPO
EXPONENT INC

2020 Q2 Form 10-Q Financial Statement

#000156459020023597 Filed on May 08, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q1
Revenue $106.0M $99.03M
YoY Change -0.52% 2.67%
Cost Of Revenue $6.200M $5.600M
YoY Change 0.0% -3.45%
Gross Profit $99.70M $93.40M
YoY Change -0.6% 2.98%
Gross Profit Margin 94.1% 94.31%
Selling, General & Admin $57.70M $72.00M
YoY Change -17.34% 16.88%
% of Gross Profit 57.87% 77.09%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.800M $1.600M
YoY Change 12.5% 0.0%
% of Gross Profit 1.81% 1.71%
Operating Expenses $69.97M $83.28M
YoY Change -14.35% 11.25%
Operating Profit $35.99M $15.75M
YoY Change 44.98% -27.06%
Interest Expense $900.0K $1.100M
YoY Change 0.0% 120.0%
% of Operating Profit 2.5% 6.98%
Other Income/Expense, Net -$11.93M $7.568M
YoY Change -396.25% 788.26%
Pretax Income $24.06M $23.32M
YoY Change -16.62% 3.88%
Income Tax -$2.227M $610.0K
% Of Pretax Income -9.26% 2.62%
Net Earnings $26.28M $22.71M
YoY Change 25.19% 11.66%
Net Earnings / Revenue 24.81% 22.93%
Basic Earnings Per Share $0.50 $0.43
Diluted Earnings Per Share $0.49 $0.42
COMMON SHARES
Basic Shares Outstanding 52.58M 52.54M
Diluted Shares Outstanding 53.66M 53.81M

Balance Sheet

Concept 2020 Q2 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $152.0M $171.8M
YoY Change -21.85% -3.81%
Cash & Equivalents $105.6M $79.08M
Short-Term Investments $46.40M $92.70M
Other Short-Term Assets $14.10M $14.00M
YoY Change 34.29% 45.83%
Inventory
Prepaid Expenses
Receivables $127.2M $6.000M
Other Receivables $0.00 $0.00
Total Short-Term Assets $293.4M $304.6M
YoY Change -12.33% -0.29%
LONG-TERM ASSETS
Property, Plant & Equipment $82.30M $50.85M
YoY Change 46.67% 25.88%
Goodwill $8.607M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $99.30M $1.024M
YoY Change 10363.65% -98.81%
Total Long-Term Assets $190.3M $184.6M
YoY Change 2.32% 36.79%
TOTAL ASSETS
Total Short-Term Assets $293.4M $304.6M
Total Long-Term Assets $190.3M $184.6M
Total Assets $483.7M $489.2M
YoY Change -7.1% 11.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $14.00M $12.40M
YoY Change -28.93% -24.85%
Accrued Expenses $51.40M $52.20M
YoY Change -20.56% 15.49%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $77.10M $72.19M
YoY Change -16.99% 3.73%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $83.10M $2.702M
YoY Change 2819.89% -95.79%
Total Long-Term Liabilities $83.10M $2.702M
YoY Change 2819.89% -95.79%
TOTAL LIABILITIES
Total Short-Term Liabilities $77.10M $72.19M
Total Long-Term Liabilities $83.10M $2.702M
Total Liabilities $160.2M $160.0M
YoY Change -9.38% 19.61%
SHAREHOLDERS EQUITY
Retained Earnings $350.5M
YoY Change
Common Stock $239.0M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $257.7M
YoY Change
Treasury Stock Shares $13.81M
Shareholders Equity $323.5M $329.2M
YoY Change
Total Liabilities & Shareholders Equity $483.7M $489.2M
YoY Change -7.1% 11.07%

Cashflow Statement

Concept 2020 Q2 2019 Q1
OPERATING ACTIVITIES
Net Income $26.28M $22.71M
YoY Change 25.19% 11.66%
Depreciation, Depletion And Amortization $1.800M $1.600M
YoY Change 12.5% 0.0%
Cash From Operating Activities -$13.84M -$12.25M
YoY Change -137.29% -431.88%
INVESTING ACTIVITIES
Capital Expenditures $1.293M $5.670M
YoY Change -119.01% -16.74%
Acquisitions
YoY Change
Other Investing Activities $9.000M -$10.80M
YoY Change 190.32% 176.92%
Cash From Investing Activities $7.707M -$16.52M
YoY Change -308.3% 53.74%
FINANCING ACTIVITIES
Cash Dividend Paid $10.31M $8.593M
YoY Change 23.48%
Common Stock Issuance & Retirement, Net $40.05M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -64.32M -19.42M
YoY Change 724.67% 27.01%
NET CHANGE
Cash From Operating Activities -13.84M -12.25M
Cash From Investing Activities 7.707M -16.52M
Cash From Financing Activities -64.32M -19.42M
Net Change In Cash -70.84M -47.98M
YoY Change -376.73% 121.69%
FREE CASH FLOW
Cash From Operating Activities -$13.84M -$12.25M
Capital Expenditures $1.293M $5.670M
Free Cash Flow -$15.13M -$17.92M
YoY Change -134.46% 474.82%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
23322000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2227000
CY2020Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
36821000
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6513000
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-11933000
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
7568000
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
24055000
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
22983000
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
672000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4095000
CY2020Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
40049000
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1673000
CY2020Q2 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
8645000
CY2020Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-15112000
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
168000
CY2020Q2 us-gaap Dividends
Dividends
10255000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
26282000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
313909000
CY2019Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
372000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3663000
CY2019Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
117000
CY2019Q1 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
7947000
CY2019Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-11194000
CY2019Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
154000
CY2019Q1 us-gaap Profit Loss
ProfitLoss
22712000
CY2020Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1786000
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
24777000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
105953000
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
99031000
CY2020Q2 expo Cost Incurred From Reimbursable Expense
CostIncurredFromReimbursableExpense
6233000
CY2019Q1 expo Cost Incurred From Reimbursable Expense
CostIncurredFromReimbursableExpense
5630000
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5531000
CY2019Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4546000
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
69965000
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
83277000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
35988000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
15754000
CY2020Q2 us-gaap Investment Income Net
InvestmentIncomeNet
875000
CY2019Q1 us-gaap Investment Income Net
InvestmentIncomeNet
1055000
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-12808000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
610000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
26282000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
22712000
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.50
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.49
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52575000
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52536000
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53657000
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53814000
CY2020Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.19
CY2019Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.16
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
26282000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
22712000
CY2020Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-1673000
CY2019Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
117000
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
168000
CY2019Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
154000
CY2020Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
7707000
CY2020Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
15112000
CY2020Q2 us-gaap Payments Of Dividends
PaymentsOfDividends
10308000
CY2020Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-64324000
CY2020Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-390000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-70842000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
350251000
CY2020Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
473000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
323497000
CY2020Q2 us-gaap Profit Loss
ProfitLoss
26282000
CY2020Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2383000
CY2020Q2 us-gaap Share Based Compensation
ShareBasedCompensation
6138000
CY2020Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1614000
CY2020Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9457000
CY2020Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
12561000
CY2020Q2 expo Increase Decrease In Operation Lease Right Of Use Assets
IncreaseDecreaseInOperationLeaseRightOfUseAssets
707000
CY2020Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-4110000
CY2020Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-24117000
CY2020Q2 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1026000
CY2020Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13835000
CY2020Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1293000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
127059000
CY2019Q1 us-gaap Dividends
Dividends
8503000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
22712000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
329177000
CY2019Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
372000
CY2019Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
8593000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-19415000
CY2019Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
207000
CY2019Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1590000
CY2020Q2 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
60000
CY2019Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
132000
CY2019Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
788000
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5731000
CY2019Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
161000
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
13838000
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
10431000
CY2019Q1 expo Increase Decrease In Operation Lease Right Of Use Assets
IncreaseDecreaseInOperationLeaseRightOfUseAssets
425000
CY2019Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-333000
CY2019Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-16477000
CY2019Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1599000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12253000
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5670000
CY2019Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
23848000
CY2020Q2 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
9000000
CY2019Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
13000000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-16518000
CY2019Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
11194000
CY2020Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
40049000
CY2020Q2 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1145000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-47979000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
176436000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
105594000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
79080000
CY2020Q2 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:7.69%;color:#auto;font-family:Times New Roman;font-weight:bold;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates. <span style="font-weight:normal;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Items subject to such estimates and assumptions include accounting for revenue recognition and estimating the allowance for contract losses and doubtful accounts. Actual results could differ from those estimates. The Company’s estimate of its allowance for contract losses and doubtful accounts takes into consideration the macroeconomic effect of global events such as the COVID-19 pandemic which may impact the ability of its customers to pay. </span></p>
CY2020Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
4791000
CY2019Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3411000
CY2020Q2 expo Subcontractor Fees Not Included In Revenues
SubcontractorFeesNotIncludedInRevenues
3781000
CY2019Q1 expo Subcontractor Fees Not Included In Revenues
SubcontractorFeesNotIncludedInRevenues
4242000
CY2020Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
120049000
CY2020Q2 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
69865000
CY2020Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
69865000
CY2020Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
172310000
CY2020Q1 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
76357000
CY2020Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
76357000
CY2020Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
151495000
CY2020Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
548000
CY2020Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0
CY2020Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
152043000
CY2020Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
231277000
CY2020Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
324000
CY2020Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0
CY2020Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
231601000
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52575000
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52536000
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53657000
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53814000
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
22418
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
24176
CY2020Q2 expo Share Based Compensation Arrangements By Share Based Payment Award Options Expiration Term
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm
P10Y
CY2016Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
35000000
CY2019Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
75000000
CY2020Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
636000
CY2020Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
40049000
CY2019Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0
CY2020Q2 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
30455000
CY2020Q2 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
68842000
CY2020Q1 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
75934000
CY2020Q2 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
69865000
CY2020Q1 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
76357000
CY2020Q2 expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
-14622000
CY2019Q1 expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
5869000
CY2020Q2 expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
8645000
CY2020Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
1231000
CY2019Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
440000
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
168000
CY2019Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
154000
CY2019Q1 expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
7947000
CY2020Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
229000
CY2019Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1903000
CY2019Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
25653000
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6192000
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4295000
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
127212000
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
120138000
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4295000
CY2020Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2383000
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
486000
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6192000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
105953000
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
99031000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
35988000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
15754000
CY2020Q2 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
1039000
CY2019Q1 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
6341000
CY2020Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1786000
CY2019Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1590000
CY2020Q2 expo Number Of Clients Comprising More Than Ten Percent Of Revenues
NumberOfClientsComprisingMoreThanTenPercentOfRevenues
0
CY2019Q1 expo Number Of Clients Comprising More Than Ten Percent Of Revenues
NumberOfClientsComprisingMoreThanTenPercentOfRevenues
0
CY2020Q2 expo Number Of Clients Comprising More Than Ten Percent Of Accounts Receivable
NumberOfClientsComprisingMoreThanTenPercentOfAccountsReceivable
0
CY2020Q1 expo Number Of Clients Comprising More Than Ten Percent Of Accounts Receivable
NumberOfClientsComprisingMoreThanTenPercentOfAccountsReceivable
0
CY2020Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y
CY2020Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
2434000
CY2019Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
2534000
CY2019Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y7M6D
CY2020Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.044
CY2019Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.045
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
4503000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
5993000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
4773000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
3187000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
2176000
CY2020Q2 expo Lessee Operating Lease Liability Payments Due Year Six
LesseeOperatingLeaseLiabilityPaymentsDueYearSix
1491000
CY2020Q2 expo Lessee Operating Lease Liability Payments Due Year Seven
LesseeOperatingLeaseLiabilityPaymentsDueYearSeven
1507000
CY2020Q2 expo Lessee Operating Lease Liability Payments Due Year Eight
LesseeOperatingLeaseLiabilityPaymentsDueYearEight
1466000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
25096000
CY2020Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
3204000
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
21892000

Files In Submission

Name View Source Status
0001564590-20-023597-index-headers.html Edgar Link pending
0001564590-20-023597-index.html Edgar Link pending
0001564590-20-023597.txt Edgar Link pending
0001564590-20-023597-xbrl.zip Edgar Link pending
expo-10q_20200403.htm Edgar Link pending
expo-10q_20200403_htm.xml Edgar Link completed
expo-20200403.xsd Edgar Link pending
expo-20200403_cal.xml Edgar Link unprocessable
expo-20200403_def.xml Edgar Link unprocessable
expo-20200403_lab.xml Edgar Link unprocessable
expo-20200403_pre.xml Edgar Link unprocessable
expo-ex311_8.htm Edgar Link pending
expo-ex312_7.htm Edgar Link pending
expo-ex321_6.htm Edgar Link pending
expo-ex322_9.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending